Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1321–1344 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Apoplexy Clear all

Conditions: Stroke
Interventions: Intensive task-specific upper extremity rehabilitation; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Atrial Fibrillation, Arrhythmia
Interventions: Not listed
Lead sponsor: Tulane University; Other
Eligibility: 20 Years to 80 Years · Female only
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Stroke
Interventions: Transcranial direct current stimulation (high- definition); Device
Lead sponsor: Carle Foundation Hospital; Other
Eligibility: 18 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Stroke
Interventions: Upper limb-based movement priming (UL-priming), Lower limb-based movement priming (LL-priming), Sham priming; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years to 90 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stroke, Muscle Spasticity
Interventions: Botox (botulinum toxin); Drug
Lead sponsor: New York Presbyterian Hospital; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiovascular Events
Interventions: Aliskiren, Amlodipine, Hydrochlorothiazide (HCTZ), Placebo for Aliskiren, Placebo for Amlodipine, Placebo for Hydrochlorothiazide (HCTZ); Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 65 Years and older
Enrollment: 2,336 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • Northridge, California + 11 more

Conditions: Atherosclerosis
Interventions: Aliskiren, Placebo; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 45 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Craniocerebral Trauma, Stroke, Intracranial Hemorrhages
Interventions: Early cranioplasty, Standard-of-care cranioplasty; Procedure
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Amyotrophic Lateral Sclerosis, Brainstem Stroke, Muscular Dystrophies, Parkinson's Disease and Parkinsonism, Multiple System Atrophy, Brain Tumor Adult, Spinal Cord Injuries, Locked-in Syndrome
Interventions: BCI-FIT multi-modal access, BCI-FIT adaptive signal modeling, BCI-FIT active querying, BCI-FIT language modeling; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Chronic Heart Failure
Interventions: Remote Ischemic Conditioning (using Sphygmomanometer); Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke, Multiple Sclerosis, Rheumatoid Arthritis
Interventions: SystemCHANGE Group Lifestyle counseling, Phone Lifestyle Counseling; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 30 Years to 75 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Ischemic Stroke
Interventions: Vivistim; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Ischemic Stroke, Thrombotic Disease
Interventions: DS-1040b, Placebo; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 16
States / cities: Mobile, Alabama • Los Angeles, California • Colorado Springs, Colorado + 13 more

Conditions: Stroke
Interventions: Arm ergometer smart trainer cycling program; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years to 70 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Homewood, Alabama

Conditions: Stroke, Muscle Spasticity, Motor Neuron Disease
Interventions: botulinum toxin Type A, saline; Biological · Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Stroke, Cognitive Dysfunction
Interventions: Speed of Processing Training, Instrumental Activities of Daily Living In-lab Training, Cognitive Transfer Packagke, Family Caregiver Coaching, Follow-up Phone Calls, Healthy Lifestyle In-lab Training, Healthy Lifestyle Transfer Package; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 40 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Asthma, Atrial Fibrillation, Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, Congestive Heart Failure, Hyperlipidemia, Hypertension, Myocardial Infarction, Sickle Cell Disease, Sleep Apnea, Smoking, Stroke, Tuberculosis
Interventions: Problem List Suggestion; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 2,386 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2016
U.S. locations: 4
States / cities: Boston, Massachusetts • Portland, Oregon • Camp Hill, Pennsylvania + 1 more

Conditions: Hemorrhagic Stroke
Interventions: In-patient and out-patient electronic health record alert; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 340 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: real rTMS combined with constraint induced therapy, sham rTMS combined with constraint induced therapy; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 8 Years to 16 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stroke, Ischemic, Motor Activity, Upper Extremity Paralysis
Interventions: Sham, Low dose tDCS, High dose tDCS, mCIMT; Device · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 11 more

Conditions: Chronic Ischemic Stroke
Interventions: SB623; Biological
Lead sponsor: SanBio, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 5
States / cities: Birmingham, Alabama • Stanford, California • Atlanta, Georgia + 2 more

Conditions: Cerebrovascular Accident
Interventions: GSK249320A, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: Occupational therapy- Repetitive Facilitative Exercise; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stroke, Patent Foramen Ovale
Interventions: AMPLATZER™ PFO Occluder; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 1,214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 78
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chandler, Arizona + 63 more

Search by objective public record fields.

Does More Practice Improve Arm Movement After Stroke?

Epigenetic Analysis of Regulation of the Inflammasome-activating NLRP3 Gene in Monocytes From Atrial Fibrillation Patients and Controls

Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments

Upper Limb-based Movement Priming for Lower Limb Neuroplasticity & Motor Recovery in Stroke

Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

Aliskiren Effect on Aortic Plaque Progression

Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes

Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit

The IMPULSE Study: Pilot

Health Promotion and Wellness Program for Adults With Disabling Conditions

Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

Smart Trainer Arm Ergometry Exercise Training in Individuals Post-Stroke

Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke

Improving Quality by Maintaining Accurate Problems in the EHR

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

Pediatric Hemiplegia: Synergistic Treatment Using rTMS and CIT

Transcranial Direct Current Stimulation for Post-stroke Motor Recovery

A Study of Modified Stem Cells in Stable Ischemic Stroke

Anti-MAG First Administration to Human

Use of Repetitive Facilitative Exercise Program in Established Stroke

AMPLATZER PFO Occluder Post Approval Study